ANTHONY B. EVNIN, PH.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Viracta Therapeutics, Inc.

Filing Date Source Excerpt
2008-04-29 Consistent with these considerations, after a review of all relevant transactions or relationships between each director, or any of his family members, and Sunesis, our senior management and our independent registered public accounting firm, the Board has affirmatively determined that Drs. Evnin, Fodor, Pearce and Stump and Messrs. Fust, Goldby and Leff, a majority of our Board, are independent directors within the meaning of the applicable NASDAQ listing requirements. ... The Compensation Committee is chaired by Dr. Evnin, and also includes Messrs. Goldby and Leff.

Data sourced from SEC filings. Last updated: 2026-03-09